BioCentury
ARTICLE | Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica deal

July 4, 2011 7:00 AM UTC

The companies partnered to develop a therapeutic discovery platform that will identify small molecules against therapeutic targets. The companies will use Cresset's field-based computational chemistry...